-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Synchron announced the completion of the first patient enrollment in a clinical trial evaluating an endovascular brain-computer interface (BCI) syst.
Brain-computer interface technology refers to the realization of information exchange between external devices and the brain by interpreting neural electrical activity signa.
Synchron's technology is called Stentrode, a matrix of electrodes implanted in blood vesse.
References:
[1] Synchron Announces Enrollment of First Patient in US Endovascular Brain Computer Interface Study COMMAND in Patients With Severe Paralys.